Cargando…
Poor allograft outcome in Indian patients with post-transplant C3 glomerulopathy
BACKGROUND: Complement 3 glomerulopathy (C3G) results from dysfunction of the alternative complement pathway (ACP). No data are available on post-transplant C3G in South Asia. METHODS: In this study, renal allograft biopsies of C3G patients performed from 2012 to 2017 were analysed for ACP functiona...
Autores principales: | Kumar, Ashwani, Ramachandran, Raja, Rawat, Amit, Das, Reena, Rayat, Charan S, Kenwar, Deepesh B, Sharma, Ashish, Gupta, Krishan L, Nada, Ritambhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857824/ https://www.ncbi.nlm.nih.gov/pubmed/33564431 http://dx.doi.org/10.1093/ckj/sfz135 |
Ejemplares similares
-
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience
por: Viswanathan, Ganesh Kumar, et al.
Publicado: (2015) -
Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy
por: Bharati, Joyita, et al.
Publicado: (2018) -
Collagenofibrotic glomerulopathy—a review
por: Duggal, Rajan, et al.
Publicado: (2012) -
Mesenchymal Stromal Cells Mediate Clinically Unpromising but Favourable Immune Responses in Kidney Transplant Patients
por: Kaundal, Urvashi, et al.
Publicado: (2022) -
Membranous Nephropathy with Collapse: Poor Prognosis
por: Bharati, Joyita, et al.
Publicado: (2020)